Lateral Canthal Lines
Pipeline by Development Stage
On Market (1)
Approved therapies currently available
Competitive Landscape
4 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
Clinical Trials (5)
Total enrollment: 1,710 patients across 5 trials
Treatment of Moderate to Severe Lateral Canthal Lines
BOTOX® in the Treatment of Crow's Feet Lines in China
Botulinum Type A Toxin in the Treatment of Lateral Canthal Lines (Crow's Feet)
Princess® RICH for the Correction of Fine Lines
Safety and Effectiveness of BOTOX® for Lateral Canthal Lines With or Without Simultaneous Glabellar Lines in Korea
Phase Legend
Key Insights
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.